Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY

v3.21.1
CONDENSED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY - 3 months ended Mar. 31, 2021 - USD ($)
Class A Common Stock
Class B Common Stock
Additional Paid-in Capital
Retained Earnings (Accumulated Deficit)
Total
Balance at the beginning at Dec. 31, 2020 $ 0 $ 719 $ 24,281 $ (13,671) $ 11,329
Balance at the beginning (in shares) at Dec. 31, 2020 0 7,187,500      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Sale of Units in initial public offering, less allocation to derivative warrant liabilities $ 2,875   277,147,125 0 277,150,000
Sale of Units in initial public offering, less allocation to derivative warrant liabilities (in shares) 28,750,000        
Offering costs     (15,806,777) 0 (15,806,777)
Sale of private placement units to Sponsor in private placement, less allocation to derivative warrant liabilities $ 80   7,711,920 0 7,712,000
Sale of private placement units to Sponsor in private placement, less allocation to derivative warrant liabilities (in shares) 800,000        
Class A ordinary shares subject to possible redemption $ (2,677)   (267,662,583) 0 (267,665,260)
Class A ordinary shares subject to possible redemption (in shares) (26,766,526)        
Net income     0 3,598,716 3,598,716
Balance at the end at Mar. 31, 2021 $ 278 $ 719 $ 1,413,966 $ 3,585,045 $ 5,000,008
Balance at the end (in shares) at Mar. 31, 2021 2,783,474 7,187,500